BioXcel Therapeutics, Inc. (BTAI) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.44
Day's range
$1.8

BioXcel Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
MILLENNIUM MANAGEMENT LLC 08/14/2026 2.11 M $2.98 M   9.19% 17.32%
OAKTREE CAPITAL MANAGEMENT LP 08/14/2026 1.38 M $1.95 M   472.27% 11.31%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 919.55 K $1.30 M   343.50% 7.53%
OAKTREE FUND ADVISORS, LLC 08/14/2026 245.59 K $346.27 K   472.29% 2.01%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 242.25 K $341.91 K   5.25% 1.98%
BLACKROCK, INC. 08/07/2026 179.43 K $253.00 K   112.90% 1.47%
UBS GROUP AG 08/13/2026 158.07 K $222.87 K   199.43% 1.29%
CITADEL ADVISORS LLC 09/02/2026 149.22 K $210.40 K   100.00% 1.22%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 136.94 K $193.08 K   61.25% 1.12%
STATE STREET CORP 09/22/2026 92.12 K $129.89 K   0.00% 0.75%
FMR LLC 08/13/2026 90.30 K $127.32 K   0.00% 0.74%
WILEY BROS.-AINTREE CAPITAL, LLC 08/14/2026 83.59 K $117.86 K   3.37% 0.68%
JONES FINANCIAL COMPANIES LLLP 08/14/2026 63.14 K $82.71 K   -52.09% 0.52%
NORTHERN TRUST CORP 08/13/2026 56.32 K $79.41 K   55.09% 0.46%
HIGHTOWER ADVISORS, LLC 08/05/2026 41.00 K $57.81 K   0.00% 0.34%
QUADRATURE CAPITAL LTD 08/07/2026 38.04 K $53.63 K   100.00% 0.31%
HEADLANDS TECHNOLOGIES LLC 08/13/2026 25.56 K $36.03 K   100.00% 0.21%
STONEX GROUP INC. 08/12/2026 20.68 K $29.16 K   100.00% 0.17%
BEACON POINTE ADVISORS, LLC 08/18/2026 18.84 K $26.56 K   -0.21% 0.15%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 17.20 K $24.25 K   100.00% 0.14%
PORTFOLIO STRATEGIES, INC. 08/10/2026 16.83 K $23.73 K   38.21% 0.14%
ADVISOR GROUP HOLDINGS, INC. 08/14/2026 16.21 K $22.86 K   0.00% 0.13%
VIRTU FINANCIAL LLC 08/13/2026 15.97 K $23.00 K   100.00% 0.13%
DIVERSIFY ADVISORY SERVICES, LLC 08/10/2026 15.00 K $13.01 K   100.00% 0.12%
DIVERSIFY WEALTH MANAGEMENT, LLC 07/30/2026 15.00 K $13.01 K   0.00% 0.12%
TWO SIGMA SECURITIES, LLC 08/14/2026 10.80 K $15.22 K   100.00% 0.09%
WELLS FARGO & COMPANY/MN 08/14/2026 4.34 K $6.12 K   0.42% 0.04%
CITIGROUP INC 08/03/2026 3.00 K $4.23 K   100.00% 0.02%
MORGAN STANLEY 08/13/2026 1.67 K $2.36 K   -84.22% 0.01%
BARCLAYS PLC 08/14/2026 1.43 K $2.01 K   100.00% 0.01%
NEWEDGE ADVISORS, LLC 08/12/2026 1.33 K $1.88 K   0.00% 0.01%
VANGUARD GLOBAL ADVISERS, LLC 08/13/2026 493 $695   0.00% 0.00%
SILVER GROVE FINANCIAL GROUP, INC. 08/13/2026 331 $468   -0.90% 0.00%
TOWER RESEARCH CAPITAL LLC (TRC) 08/11/2026 227 $320   -86.79% 0.00%
PARKSIDE FINANCIAL BANK & TRUST 09/04/2026 112 $158   0.00% 0.00%
WASHINGTON TRUST ADVISORS, INC. 07/29/2026 82 $116   -48.75% 0.00%
EVERSOURCE WEALTH ADVISORS, LLC 07/24/2026 60 $85   0.00% 0.00%
JPMORGAN CHASE & CO 08/12/2026 45 $63   0.00% 0.00%
MERCER GLOBAL ADVISORS INC /ADV 08/11/2026 32 $45   100.00% 0.00%
FARTHER FINANCE ADVISORS, LLC 07/17/2026 25 $35   0.00% 0.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 08/12/2026 21 $30   0.00% 0.00%
IFP ADVISORS, INC 07/20/2026 13 $18   0.00% 0.00%
SBI SECURITIES CO., LTD. 07/23/2026 13 $18   -7.14% 0.00%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 12 $17   -79.66% 0.00%
ZURCHER KANTONALBANK (ZURICH CANTONALBANK) 08/12/2026 2 $3   0.00% 0.00%
US BANCORP \DE\ 08/12/2026 1 $1   0.00% 0.00%
GROUP ONE TRADING, L.P. 08/14/2026 1 $1   0.00% 0.00%
TRIUMPH CAPITAL MANAGEMENT 07/21/2026 1 $1   0.00% 0.00%
ARMISTICE CAPITAL, LLC 08/14/2026 0 $0   -100.00% 0.00%
MAN GROUP PLC 08/14/2026 0 $0   -100.00% 0.00%

BioXcel Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 62 institutional investors and hedge funds held shares of BioXcel Therapeutics Inc. The most heavily invested institutionals were:

MILLENNIUM MANAGEMENT LLC: 2.11 M

OAKTREE CAPITAL MANAGEMENT LP: 1.38 M

VANGUARD CAPITAL MANAGEMENT LLC: 919,545

Oaktree Fund Advisors, LLC: 245,585

GEODE CAPITAL MANAGEMENT, LLC: 242,251

BlackRock, Inc.: 179,433

50.59% of BioXcel Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 6.92 M shares in the last 24 months. This purchase volume represents approximately $11.97 M in transactions.